Skip to content

Clinical trials

Phase 2 Glomerulonephritis, IGA trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulonephritis, IGA Phase: Phase 2 Country / region: Australia Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20191
20201
20213
20222
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting3
Terminated3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Alexion Pharmaceuticals, Inc.2
ADARx Pharmaceuticals, Inc.1
Eledon Pharmaceuticals1
HI-Bio, A Biogen Company1
Ionis Pharmaceuticals, Inc.1
Jade Biosciences, Inc.1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Walden Biosciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulonephritis, IGA12
Glomerulonephritis4
Kidney Diseases4
Proteinuria3
Urologic Diseases3
Autoimmune Diseases2
Diabetic Nephropathies2
Immune System Diseases2
Lupus Nephritis2
Nephritis2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.